1. Home
  2. TSE vs PMCB Comparison

TSE vs PMCB Comparison

Compare TSE & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinseo PLC

TSE

Trinseo PLC

HOLD

Current Price

$0.23

Market Cap

8.3M

Sector

Industrials

ML Signal

HOLD

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

N/A

Current Price

$0.75

Market Cap

8.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TSE
PMCB
Founded
2010
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
8.3M
IPO Year
2014
2001

Fundamental Metrics

Financial Performance
Metric
TSE
PMCB
Price
$0.23
$0.75
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
749.8K
101.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
50.40
277.22
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.63
52 Week High
$4.66
$1.82

Technical Indicators

Market Signals
Indicator
TSE
PMCB
Relative Strength Index (RSI) 27.26 52.42
Support Level N/A $0.66
Resistance Level $0.51 $1.05
Average True Range (ATR) 0.06 0.06
MACD -0.01 0.01
Stochastic Oscillator 0.33 84.26

Price Performance

Historical Comparison
TSE
PMCB

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: